Working… Menu

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (TRAIN-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03820063
Recruitment Status : Recruiting
First Posted : January 29, 2019
Last Update Posted : July 10, 2020
Roche Pharma AG
BOOG Study Center
Information provided by (Responsible Party):
Borstkanker Onderzoek Groep

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 1, 2022
Estimated Study Completion Date : February 1, 2032